Catabasis Pharmaceuticals, Inc. (CATB) Social Stream



Catabasis Pharmaceuticals, Inc. (CATB): $8.54

-0.64 (-6.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CATB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 510

in industry

Featured Post From StockTwits About CATB

$CATB Analysts’ Opinion of CATB
Many brokerage firms have already submitted their reports for CATB stocks, with Ladenburg Thalmann repeating the rating for CATB by listing it as a “Buy.” The predicted price for CATB in the upcoming period, according to Ladenburg Thalmann is $6 based on the research report published on May 12th of the current year 2021.

Oppenheimer, on the other hand, stated in their research note that they expect to see CATB reach a price target of $5. The rating they have provided for CATB stocks is “Outperform” according to the report published on March 11th, 2021.

https://newsheater.com/2021/08/11/wall-street-pummels-catabasis-pharmaceuticals-inc-catb-after-recent-earnings-report/
Sanh91, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4339 seconds.